AI in Telehealth Market - 2026-2035

June 2026 | 42 pages | ID: AE7EDD516C7FEN
DataM Intelligence

Abstracts

AI in Telehealth Market reached US$ 5.58 Billion in 2025 and is expected to reach US$ 59.78 billion by 2035, growing with a CAGR of 26.80% during the forecast period 2026-2035.

The AI in Telehealth Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A AI in Telehealth Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By AI Application

• AI Triage and Symptom Assessment*
• Predictive Analytics and Risk Stratification
• Automated Diagnostic Support
• CDS (Clinical Decision Support)
• Virtual Assistants and Patient Navigation
• AI Enabled RPM Alert Prioritization
• AI Enabled Care Recommendation
• AI Enabled Documentation and Workflow Automation
• AI Enabled Patient Engagement
• Others

By Offering

• Software*
• Services
• Hardware Enabled Solution Components

By Care Delivery Model

• Synchronous Telehealth*
• Asynchronous Telehealth
• AI Enabled RPM (Remote Patient Monitoring)
• Mobile Health Based Virtual Care
• Hybrid Virtual Care
• Others

By Deployment Model

• Cloud Based*
• On Premise
• Hybrid

By End-User

• Hospitals and Health Systems*
• Clinics and Physician Practices
• Telehealth Service Providers
• Home Healthcare Providers
• Government Healthcare Programs
• Payers and Insurance Providers
• Employers
• Patients and Direct Consumers
• Others

By Business Model

• Subscription*
• Per Consultation Fee
• Per Patient Monitoring Fee
• Per User License
• Per Provider License
• Enterprise Platform Contract
• Managed Service Contract
• Outcome Linked Contracting
• Others

Regional Analysis for AI in Telehealth Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global AI in Telehealth Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Data
  1.1.1. Secondary Data
  1.1.2. Primary Data
  1.1.3. CAGR Analysis
1.2. Market Size Estimation Methodology
  1.2.1. Bottom-Up Approach
  1.2.2. Top-Down Approach
1.3. Market Breakdown and Data Triangulation
1.4. Research Assumptions
1.5. Limitations

2. DEFINITION AND OVERVIEW

2.1. Study Objectives
2.2. Market Definition
2.3. Market Scope
2.4. Stakeholder Analysis
2.5. Currency Considered
2.6. Study Period

3. EXECUTIVE SUMMARY

3.1. Key Takeaways
3.2. Top To Bottom Analysis
3.3. Market Share Analysis
3.4. Data Points From Key Primary Interviews
3.5. Data Points From Key Secondary Databases
3.6. Market Snapshot
3.7. Geographical Snapshot

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. AI Triage Is Becoming The Digital Front Door For Virtual Care
    4.1.1.2. Provider Shortages Are Pushing AI Into Pre Consultation Workflows
    4.1.1.3. AI Enabled RPM Is Moving From Passive Monitoring To Clinical Escalation
  4.1.2. Restraints
    4.1.2.1. Clinical Validation Gaps Slow Provider Trust In AI Recommendations
    4.1.2.2. Data Localization and Privacy Rules Limit Cross Border AI Deployment
  4.1.3. Impact Analysis - Drivers and Restraints
  4.1.4. Opportunities
    4.1.4.1. Arabic Language AI Assistants For Saudi and Gulf Telehealth Platforms
    4.1.4.2. AI Supported Specialist Access For Underserved and Remote Care Networks
  4.1.5. Trends
    4.1.5.1. Virtual Care Vendors Are Embedding AI Scribes Into Teleconsultation Workflows
    4.1.5.2. Health Systems Are Asking For AI Governance Before Full Scale Deployment
  4.1.6. Challenges

5. INDUSTRY ANALYSIS

5.1. Porter’s Five Force Analysis
5.2. Political Factors
5.3. Social Factors
  5.3.1. High Digital Comfort Is Making Virtual Health Intake Easier To Adopt
  5.3.2. Patient Trust Depends On Clear Human Oversight In AI Guided Care
  5.3.3. Family Centered Care Culture Raises Demand For Easy Care Navigation
5.4. Economic Factors
  5.4.1. Workforce Pressure Is Making Automated Intake More Valuable
  5.4.2. Cloud Based AI Platforms Reduce Heavy Upfront Technology Spending
  5.4.3. Payer Interest Is Rising Around Triage Led Avoidable Visit Reduction
5.5. Technological Factors
5.6. Geopolitical Factors
5.7. Supply and Value Chain Analysis
5.8. Pricing Analysis
5.9. Regulatory Analysis
5.10. Innovation and Research and Development Trends
5.11. Sustainability and ESG Analysis
5.12. Risk Avoidance Model
5.13. Go-To-Market Strategy
5.14. BCG Matrix
5.15. Business Models Analysis
5.16. Demand-Supply Gap
5.17. Risk Mitigation Framework
5.18. Compliance Roadmap
5.19. Strategic Implications
5.20. Emerging Opportunities
5.21. Adoption Trends
5.22. Disruption Analysis
5.23. DMI Opinion

6. BY AI APPLICATION

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By AI Application
  6.1.2. Market Attractiveness Index, By AI Application
6.2. AI Triage and Symptom Assessment*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis
6.3. Predictive Analytics and Risk Stratification
6.4. Automated Diagnostic Support
6.5. CDS (Clinical Decision Support)
6.6. Virtual Assistants and Patient Navigation
6.7. AI Enabled RPM Alert Prioritization
6.8. AI Enabled Care Recommendation
6.9. AI Enabled Documentation and Workflow Automation
6.10. AI Enabled Patient Engagement
6.11. Others

7. BY OFFERING

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By Offering
  7.1.2. Market Attractiveness Index, By Offering
7.2. Software*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis
7.3. Services
7.4. Hardware Enabled Solution Components

8. BY CARE DELIVERY MODEL

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By Care Delivery Model
  8.1.2. Market Attractiveness Index, By Care Delivery Model
8.2. Synchronous Telehealth*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis
8.3. Asynchronous Telehealth
8.4. AI Enabled RPM (Remote Patient Monitoring)
8.5. Mobile Health Based Virtual Care
8.6. Hybrid Virtual Care
8.7. Others

9. BY DEPLOYMENT MODEL

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By Deployment Model
  9.1.2. Market Attractiveness Index, By Deployment Model
9.2. Cloud Based*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis
9.3. On Premise
9.4. Hybrid

10. BY END-USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By End-User
  10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals and Health Systems*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis
10.3. Clinics and Physician Practices
10.4. Telehealth Service Providers
10.5. Home Healthcare Providers
10.6. Government Healthcare Programs
10.7. Payers and Insurance Providers
10.8. Employers
10.9. Patients and Direct Consumers
10.10. Others

11. BY BUSINESS MODEL

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By Business Model
  11.1.2. Market Attractiveness Index, By Business Model
11.2. Subscription*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis
11.3. Per Consultation Fee
11.4. Per Patient Monitoring Fee
11.5. Per User License
11.6. Per Provider License
11.7. Enterprise Platform Contract
11.8. Managed Service Contract
11.9. Outcome Linked Contracting
11.10. Others

12. BY REGION

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis, By Region
  12.1.2. Market Attractiveness index, By Region
12.2. North America
  12.2.1. Introduction
  12.2.2. Key Region-Specific Dynamics
  12.2.3. Market Size Analysis and Y-o-Y Growth Analysis, By AI Application
  12.2.4. Market Size Analysis and Y-o-Y Growth Analysis, By Offering
  12.2.5. Market Size Analysis and Y-o-Y Growth Analysis, By Care Delivery Model
  12.2.6. Market Size Analysis and Y-o-Y Growth Analysis, By Deployment Model
  12.2.7. Market Size Analysis and Y-o-Y Growth Analysis, By End-User
  12.2.8. Market Size Analysis and Y-o-Y Growth Analysis, By Business Model
  12.2.9. Market Size Analysis and Y-o-Y Growth Analysis, By Country
    12.2.9.1. U.S.
    12.2.9.2. Canada
    12.2.9.3. Mexico
12.3. Europe
  12.3.1. Introduction
  12.3.2. Key Region-Specific Dynamics
  12.3.3. Market Size Analysis and Y-o-Y Growth Analysis, By AI Application
  12.3.4. Market Size Analysis and Y-o-Y Growth Analysis, By Offering
  12.3.5. Market Size Analysis and Y-o-Y Growth Analysis, By Care Delivery Model
  12.3.6. Market Size Analysis and Y-o-Y Growth Analysis, By Deployment Model
  12.3.7. Market Size Analysis and Y-o-Y Growth Analysis, By End-User
  12.3.8. Market Size Analysis and Y-o-Y Growth Analysis, By Business Model
  12.3.9. Market Size Analysis and Y-o-Y Growth Analysis, By Country
    12.3.9.1. Germany
    12.3.9.2. UK
    12.3.9.3. France
    12.3.9.4. Russia
    12.3.9.5. Spain
    12.3.9.6. Italy
    12.3.9.7. Poland
    12.3.9.8. Rest Of Europe
12.4. South America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis and Y-o-Y Growth Analysis, By AI Application
  12.4.4. Market Size Analysis and Y-o-Y Growth Analysis, By Offering
  12.4.5. Market Size Analysis and Y-o-Y Growth Analysis, By Care Delivery Model
  12.4.6. Market Size Analysis and Y-o-Y Growth Analysis, By Deployment Model
  12.4.7. Market Size Analysis and Y-o-Y Growth Analysis, By End-User
  12.4.8. Market Size Analysis and Y-o-Y Growth Analysis, By Business Model
  12.4.9. Market Size Analysis and Y-o-Y Growth Analysis, By Country
    12.4.9.1. Brazil
    12.4.9.2. Argentina
    12.4.9.3. Rest Of South America
12.5. Asia-Pacific
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis and Y-o-Y Growth Analysis, By AI Application
  12.5.4. Market Size Analysis and Y-o-Y Growth Analysis, By Offering
  12.5.5. Market Size Analysis and Y-o-Y Growth Analysis, By Care Delivery Model
  12.5.6. Market Size Analysis and Y-o-Y Growth Analysis, By Deployment Model
  12.5.7. Market Size Analysis and Y-o-Y Growth Analysis, By End-User
  12.5.8. Market Size Analysis and Y-o-Y Growth Analysis, By Business Model
  12.5.9. Market Size Analysis and Y-o-Y Growth Analysis, By Country
    12.5.9.1. China
    12.5.9.2. India
    12.5.9.3. Japan
    12.5.9.4. Australia
    12.5.9.5. South Korea
    12.5.9.6. Indonesia
    12.5.9.7. Malaysia
    12.5.9.8. Rest Of Asia-Pacific
12.6. Middle East and Africa
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis and Y-o-Y Growth Analysis, By AI Application
  12.6.4. Market Size Analysis and Y-o-Y Growth Analysis, By Offering
  12.6.5. Market Size Analysis and Y-o-Y Growth Analysis, By Care Delivery Model
  12.6.6. Market Size Analysis and Y-o-Y Growth Analysis, By Deployment Model
  12.6.7. Market Size Analysis and Y-o-Y Growth Analysis, By End-User
  12.6.8. Market Size Analysis and Y-o-Y Growth Analysis, By Business Model
  12.6.9. Market Size Analysis and Y-o-Y Growth Analysis, By Country
    12.6.9.1. UAE
    12.6.9.2. Saudi Arabia
    12.6.9.3. South Africa
    12.6.9.4. Israel
    12.6.9.5. Turkiye
    12.6.9.6. Rest Of Middle East and Africa

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Share Analysis 2025 - Global
13.3. Mergers and Acquisitions Analysis
13.4. Partner Identification Analysis
13.5. Investment and Funding Landscape
13.6. Strategic Alliances and Innovation Pipeline

14. COMPANY PROFILES

14.1. Teladoc Health, Inc.*
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Revenue Analysis
  14.1.4. Pricing Analysis
  14.1.5. SWOT Analysis
  14.1.6. Recent Developments
    14.1.6.1. Major Deals
    14.1.6.2. Mergers and Acquisitions
    14.1.6.3. Collaboration
    14.1.6.4. Acquisition
    14.1.6.5. Joint Ventures
    14.1.6.6. Innovations
  14.1.7. Recent News
    14.1.7.1. Events
    14.1.7.2. Conferences
    14.1.7.3. Symposiums
    14.1.7.4. Webinars
14.2. American Well Corporation
14.3. Koninklijke Philips N.V.
14.4. GE HealthCare Technologies Inc.
14.5. Medtronic plc
14.6. Abbott Laboratories
14.7. Boston Scientific Corporation
14.8. OMRON Healthcare Co., Ltd.
14.9. Masimo Corporation
14.10. iRhythm Technologies, Inc.
14.11. DexCom, Inc.
14.12. ResMed Inc.
14.13. Huma Therapeutics Limited
14.14. Biofourmis, Inc.
14.15. TytoCare Ltd.
14.16. AliveCor, Inc.
14.17. Ada Health GmbH
14.18. Infermedica Sp. z o.o.
14.19. K Health, Inc.
14.20. Best Buy Health, Inc. (LIST NOT EXHAUSTIVE)

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us